Read all posts

New Drug to Treat Obesity Gains Approval by F.D.A.

Can the third time be the charm for weight loss pills? The Food and Drug Administration on Wednesday approved the third new prescription drug for obesity since 2012. The drug, called Contrave, was developed by Orexigen Therapeutics, a small company based in San Diego, and will be marketed by Takeda Pharmaceutical of Japan.

Read the article on Nytimes

Dr. Sears Comments:

Dr. Barry Sears

The reason why the first two new obesity drugs have not sold well is because they don’t work effectively. This new drug should be no different. The only obesity drug that sold well was Fen-Phen because it shut down appetite very effectively. Of course, it had a few side effects like death, but it worked very well in those who didn’t die.

Leave a Reply

Your email address will not be published. Required fields are marked *